Mediscience forms Asian clinical research network
This article was originally published in Scrip
The Japanese pharmaceutical contract research organisation Mediscience Planning has formed an alliance with two other operations in Asia to strengthen its capabilities for regional clinical development. It will work with the Taiwanese subsidiary of the US CRO PRA International and South Korea's LSK Global Pharma Services to offer customers a network for performing Asian multinational trials and accessing other contract services from the three firms. Mediscience raised around $6 million in its recent float on the Hercules exchange in Japan, and provides a range of regulatory, data management, clinical and other services (Scrip Online, October 15th, 2008).